Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
The risk of low blood sugar may increase when used with insulin or a sulfonylurea medicine
GLP-1 Compounded Medications Targeted by Connecticut Attorney General On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications
Our fulfillment process supports laboratories, researchers, and analytical facilities that require dependable access to research materials without unnecessary shipping delays or fulfillment uncertainty
Excess food intake or rapid gastric emptying that exceeds the absorptive capacity of the upper small intestine increases the amount of unabsorbed nutrients in the lumen of the more distally located small intestine, thereby increasing the amount of GLP-1 secretion
While not yet FDA-approved specifically for weight loss, many medical providers, including Transform Health Creations, prescribe it off-label for this purpose based on clinical evidence
